Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2019 6
2020 9
2021 2
2022 13
2023 7
2024 8

Text availability

Article attribute

Article type

Publication date

Search Results

44 results

Results by year

Filters applied: . Clear all
Page 1
Target gene regulatory network of miR-497 in angiosarcoma.
Benton A, Terwilliger E, Moriarty NM, Liu B, Murphy A, Maluvac H, Shu M, Gartenhaus LE, Janson ND, Pfeffer CM, Utturkar SM, Parkinson EI, Lanman NA, Hanna JA. Benton A, et al. Among authors: lanman na. bioRxiv [Preprint]. 2023 Sep 25:2023.09.24.559218. doi: 10.1101/2023.09.24.559218. bioRxiv. 2023. Update in: Mol Cancer Res. 2024 May 21. doi: 10.1158/1541-7786.MCR-23-1075. PMID: 37808715 Free PMC article. Updated. Preprint.
GSTM2 is a key molecular determinant of resistance to SG-ARIs.
Li C, Liu J, He D, Mao F, Rao X, Zhao Y, Lanman NA, Kazemian M, Farah E, Liu J, Ngule CM, Zhang Z, Zhang Y, Kong Y, Li L, Wang C, Liu X. Li C, et al. Among authors: lanman na. Oncogene. 2022 Sep;41(40):4498-4511. doi: 10.1038/s41388-022-02444-1. Epub 2022 Aug 29. Oncogene. 2022. PMID: 36038661 Free PMC article.
miR-497 target gene regulatory network in angiosarcoma.
Benton A, Moriarty NM, Terwilliger E, Liu B, Murphy A, Maluvac H, Shu M, Gartenhaus LE, Janson ND, Pfeffer CM, Utturkar SM, Parkinson EI, Lanman NA, Hanna JA. Benton A, et al. Among authors: lanman na. Mol Cancer Res. 2024 May 21. doi: 10.1158/1541-7786.MCR-23-1075. Online ahead of print. Mol Cancer Res. 2024. PMID: 38771248
TNF is a potential therapeutic target to suppress prostatic inflammation and hyperplasia in autoimmune disease.
Vickman RE, Aaron-Brooks L, Zhang R, Lanman NA, Lapin B, Gil V, Greenberg M, Sasaki T, Cresswell GM, Broman MM, Paez JS, Petkewicz J, Talaty P, Helfand BT, Glaser AP, Wang CH, Franco OE, Ratliff TL, Nastiuk KL, Crawford SE, Hayward SW. Vickman RE, et al. Among authors: lanman na. Nat Commun. 2022 Apr 19;13(1):2133. doi: 10.1038/s41467-022-29719-1. Nat Commun. 2022. PMID: 35440548 Free PMC article.
44 results